Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Mélanie Gaignage"'
Autor:
Grégoire de Streel, Charlotte Bertrand, Nicolas Chalon, Stéphanie Liénart, Orian Bricard, Sara Lecomte, Julien Devreux, Mélanie Gaignage, Gitte De Boeck, Lore Mariën, Inge Van De Walle, Bas van der Woning, Michael Saunders, Hans de Haard, Elien Vermeersch, Wim Maes, Hans Deckmyn, Pierre G. Coulie, Nicolas van Baren, Sophie Lucas
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-15 (2020)
Inhibiting TGF-β1 to increase immune responses against tumors bears the risk of tumor-promoting toxicity. Here the authors show that selectively blocking TGF-β1 produced by immunosuppressive cells is feasible with anti-GARP:TGF-β1 antibodies and i
Externí odkaz:
https://doaj.org/article/8a55d3ad04c940c5ae3df3fd9a81d1dc
Autor:
Mélanie Gaignage, Reece G. Marillier, Perrine M. Cochez, Laure Dumoutier, Catherine Uyttenhove, Jean-Paul Coutelier, Jacques Van Snick
Publikováno v:
Haematologica, Vol 104, Iss 2 (2019)
In spite of considerable therapeutic progress, acute graft-versus-host disease still limits allogeneic hematopoietic cell transplantation. We recently reported that mouse infection with nidovirus lactate dehydrogenase elevating virus impairs disease
Externí odkaz:
https://doaj.org/article/422fcf45535c43e9a8ec9212d0bb09f3
Autor:
Mélanie Gaignage, Xuhao Zhang, Julie Stockis, Olivier Dedobbeleer, Camille Michiels, Perrine Cochez, Laure Dumoutier, Pierre G. Coulie, Sophie Lucas
Publikováno v:
Cancer immunology, immunotherapy : CII, Vol. 00, no.00, p. 00 (2022)
Transmembrane protein GARP binds latent TGF-β1 to form GARP:(latent)TGF-β1 complexes on the surface of several cell types including Tregs, B-cells, and platelets. Upon stimulation, these cells release active TGF-β1. Blocking TGF-β1 activation by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65823b2185ada761050520ef685d8b53
https://hdl.handle.net/2078.1/258446
https://hdl.handle.net/2078.1/258446
Autor:
Shozo Izui, Dan Su, Cor Breukel, J. Sjef Verbeek, Jill W. C. Claassens, Mélanie Gaignage, Conny Brouwers, Jean-Paul Coutelier, Margot M. Linssen, Sarah Legrain
Publikováno v:
International Journal of Molecular Sciences, 22(16). MDPI
International Journal of Molecular Sciences
Volume 22
Issue 16
International Journal of Molecular Sciences, Vol 22, Iss 9027, p 9027 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 16
International Journal of Molecular Sciences, Vol 22, Iss 9027, p 9027 (2021)
Infection with viruses, such as the lactate dehydrogenase-elevating virus (LDV), is known to trigger the onset of autoimmune anemia through the enhancement of the phagocytosis of autoantibody-opsonized erythrocytes by activated macrophages. Type I in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aebe3f03de742beeb5288e00b271c01
https://hdl.handle.net/1887/3213013
https://hdl.handle.net/1887/3213013
Autor:
Christophe Bourdeaux, Paméla Chéou, Mohamed F. Mandour, Mélanie Gaignage, Jacques Van Snick, Lindsay L. Jones, Catherine Uyttenhove, Dario A. A. Vignali, Jean-Paul Coutelier
Publikováno v:
European Journal of Immunolgy, Vol. 51, no.6, p. 1482-1493 (2021)
The dimeric cytokine IL-12 is important in the control of various infections but also contributes to the pathology of certain diseases making it a potential target for therapy. However, its specific inhibition with antibodies is complicated by the fa
Autor:
Christophe Bourdeaux, Paméla Chéou, Lindsay L. Jones, Mohamed F. Mandour, Catherine Uyttenhove, Jacques Van Snick, Dario A. A. Vignali, Jean-Paul Coutelier, Mélanie Gaignage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e996b304d5790a5985088ebb980c7828
https://doi.org/10.1002/eji.202048936/v2/response1
https://doi.org/10.1002/eji.202048936/v2/response1
Autor:
Nicolas van Baren, Bas van der Woning, Grégoire de Streel, Gitte De Boeck, Hans Deckmyn, Sara Lecomte, Nicolas Chalon, Elien Vermeersch, Julien Devreux, Inge Van de Walle, Pierre Coulie, Hans de Haard, Mélanie Gaignage, Lore Mariën, Sophie Lucas, Wim Maes, Michael A. Saunders, Stéphanie Liénart, Charlotte Bertrand, Orian Bricard
Publikováno v:
Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-15 (2020)
Nature communications, Vol. 11, no.1, p. 4545 (2020)
Nature Communications, Vol 11, Iss 1, Pp 1-15 (2020)
Nature communications, Vol. 11, no.1, p. 4545 (2020)
TGF-β1, β2 and β3 bind a common receptor to exert vastly diverse effects in cancer, supporting either tumor progression by favoring metastases and inhibiting anti-tumor immunity, or tumor suppression by inhibiting malignant cell proliferation. Glo
Autor:
Dominique Donckers, Vincent Van Pesch, Catherine Uyttenhove, Paméla Chéou, Ludovic D'Auria, Zakia Nasr, Mélanie Gaignage, Jacques Van Snick
Publikováno v:
European journal of immunology, (2018)
The pathogenic role of IL-17 and GM-CSF has been unravelled in experimental autoimmune encephalomyelitis (EAE), a murine model of multiple sclerosis (MS). However, in most models, EAE is characterised by a monophasic attack which is not representativ
Autor:
Nicolas Dauguet, Thomas Michiels, Mélanie Gaignage, Bernard Ryffel, Reece Gerrad Marillier, Jacques Van Snick, Jean-Paul Coutelier, Catherine Uyttenhove, Anubha Saxena
Publikováno v:
Immunity, Inflammation and Disease. 5:200-213
Introduction Viruses have developed multiple mechanisms to alter immune reactions. In 1969, it was reported that lactate dehydrogenase-elevating virus (LDV), a single stranded positive sense mouse nidovirus, delays skin allograft rejection and inhibi
Autor:
Daniel Eastwood, Calvin B. Williams, Cheng Yin-Yuan, Jacques Van Snick, Nico Ghilardi, Kimberle A. Agle, Vivian Zhou, Reece G Marillier, Richard A. Komorowski, Ludovic Belle, Daniel J. Cua, Jie Sun, Brent R. Logan, William R. Drobyski, Mélanie Gaignage
Publikováno v:
Blood. 128:2068-2082
Reestablishment of competent regulatory pathways has emerged as a strategy to reduce the severity of graft-versus-host disease (GVHD), and recalibrate the effector and regulatory arms of the immune system. However, clinically feasible, cost-effective